
Group Structure
View All
Industry
Hospital activities
+2Registered Address
whitefriars lewins mead, bristol, BS1 2NT
Website
http://aboveandbeyond.org.ukPomanda estimates the enterprise value of UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY at £1.8m based on a Turnover of £3.3m and 0.55x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY at £733.7k based on an EBITDA of £163.5k and a 4.49x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY at £45.3m based on Net Assets of £18.7m and 2.43x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
University Hospitals Bristol & Weston Charity is a live company located in bristol, BS1 2NT with a Companies House number of 10394287. It operates in the hospital activities sector, SIC Code 86101. Founded in September 2016, it's largest shareholder is unknown. University Hospitals Bristol & Weston Charity is a young, small sized company, Pomanda has estimated its turnover at £3.3m with healthy growth in recent years.
Pomanda's financial health check has awarded University Hospitals Bristol & Weston Charity a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
3 Weak
Size
annual sales of £3.3m, make it larger than the average company (£2m)
£3.3m - University Hospitals Bristol & Weston Charity
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (7.2%)
5% - University Hospitals Bristol & Weston Charity
7.2% - Industry AVG
Production
with a gross margin of 46.7%, this company has a comparable cost of product (46.7%)
46.7% - University Hospitals Bristol & Weston Charity
46.7% - Industry AVG
Profitability
an operating margin of 5% make it as profitable than the average company (6.2%)
5% - University Hospitals Bristol & Weston Charity
6.2% - Industry AVG
Employees
with 28 employees, this is similar to the industry average (29)
28 - University Hospitals Bristol & Weston Charity
29 - Industry AVG
Pay Structure
on an average salary of £38.1k, the company has a higher pay structure (£28.4k)
£38.1k - University Hospitals Bristol & Weston Charity
£28.4k - Industry AVG
Efficiency
resulting in sales per employee of £116.7k, this is more efficient (£53.6k)
£116.7k - University Hospitals Bristol & Weston Charity
£53.6k - Industry AVG
Debtor Days
it gets paid by customers after 4 days, this is earlier than average (18 days)
4 days - University Hospitals Bristol & Weston Charity
18 days - Industry AVG
Creditor Days
its suppliers are paid after 216 days, this is slower than average (18 days)
216 days - University Hospitals Bristol & Weston Charity
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - University Hospitals Bristol & Weston Charity
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 36 weeks, this is less cash available to meet short term requirements (135 weeks)
36 weeks - University Hospitals Bristol & Weston Charity
135 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 17.3%, this is a lower level of debt than the average (25.6%)
17.3% - University Hospitals Bristol & Weston Charity
25.6% - Industry AVG
University Hospitals Bristol & Weston Charity's latest turnover from March 2024 is £3.3 million and the company has net assets of £18.7 million. According to their latest financial statements, University Hospitals Bristol & Weston Charity has 28 employees and maintains cash reserves of £2.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Sep 2018 | Mar 2017 | |
---|---|---|---|---|---|---|---|---|
Turnover | 3,267,000 | 2,454,000 | 2,643,000 | 2,839,000 | 2,571,000 | 3,041,000 | 8,085,000 | |
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | 124,000 | -2,080,000 | 1,964,000 | 962,000 | -2,777,000 | 55,000 | 2,904,000 | |
Tax | ||||||||
Profit After Tax | 124,000 | -2,080,000 | 1,964,000 | 962,000 | -2,777,000 | 55,000 | 2,904,000 | |
Dividends Paid | ||||||||
Retained Profit | 124,000 | -2,080,000 | 1,964,000 | 962,000 | -2,777,000 | 55,000 | 2,904,000 | |
Employee Costs | 1,067,000 | 974,000 | 888,000 | 977,000 | 1,002,000 | 385,000 | 1,129,000 | |
Number Of Employees | 28 | 28 | 28 | 28 | 28 | 22 | 21 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Sep 2018 | Mar 2017 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 189,000 | 233,000 | 275,000 | 313,000 | 349,000 | 569,000 | 480,000 | |
Intangible Assets | 1,000 | 1,000 | 2,000 | 3,000 | 2,000 | |||
Investments & Other | 17,281,000 | 16,724,000 | 17,358,000 | 16,500,000 | 15,232,000 | 16,400,000 | 16,933,000 | |
Debtors (Due After 1 year) | 1,727,000 | 2,208,000 | 2,669,000 | 3,108,000 | 3,528,000 | 3,929,000 | 2,925,000 | |
Total Fixed Assets | 19,198,000 | 19,166,000 | 20,304,000 | 19,924,000 | 19,111,000 | 20,898,000 | 20,338,000 | |
Stock & work in progress | ||||||||
Trade Debtors | 37,000 | 26,000 | 15,000 | 6,000 | 18,000 | 7,000 | 123,000 | |
Group Debtors | 14,000 | 14,000 | ||||||
Misc Debtors | 1,065,000 | 747,000 | 1,117,000 | 1,087,000 | 1,818,000 | 2,838,000 | 1,791,000 | |
Cash | 2,287,000 | 3,451,000 | 4,660,000 | 5,550,000 | 6,306,000 | 6,239,000 | 5,152,000 | |
misc current assets | ||||||||
total current assets | 3,389,000 | 4,224,000 | 5,792,000 | 6,643,000 | 8,156,000 | 9,098,000 | 7,066,000 | |
total assets | 22,587,000 | 23,390,000 | 26,096,000 | 26,567,000 | 27,267,000 | 29,996,000 | 27,404,000 | |
Bank overdraft | 408,000 | 380,000 | 353,000 | 331,000 | 320,000 | |||
Bank loan | ||||||||
Trade Creditors | 1,034,000 | 497,000 | 400,000 | 284,000 | 1,923,000 | 285,000 | 256,000 | |
Group/Directors Accounts | ||||||||
other short term finances | 470,000 | 438,000 | ||||||
hp & lease commitments | ||||||||
other current liabilities | 1,771,000 | 2,797,000 | 3,114,000 | 3,785,000 | 4,955,000 | 4,468,000 | 4,174,000 | |
total current liabilities | 3,275,000 | 3,732,000 | 3,922,000 | 4,449,000 | 7,231,000 | 5,084,000 | 4,750,000 | |
loans | 634,000 | 1,104,000 | 1,540,000 | 1,948,000 | 2,328,000 | 2,679,000 | 2,849,000 | |
hp & lease commitments | ||||||||
Accruals and Deferred Income | ||||||||
other liabilities | 1,500,000 | 1,748,000 | 329,000 | |||||
provisions | ||||||||
total long term liabilities | 634,000 | 1,104,000 | 1,540,000 | 3,448,000 | 2,328,000 | 4,427,000 | 3,178,000 | |
total liabilities | 3,909,000 | 4,836,000 | 5,462,000 | 7,897,000 | 9,559,000 | 9,511,000 | 7,928,000 | |
net assets | 18,678,000 | 18,554,000 | 20,634,000 | 18,670,000 | 17,708,000 | 20,485,000 | 19,476,000 | |
total shareholders funds | 18,678,000 | 18,554,000 | 20,634,000 | 18,670,000 | 17,708,000 | 20,485,000 | 19,476,000 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Sep 2018 | Mar 2017 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 43,000 | 42,000 | 32,000 | 9,000 | ||||
Amortisation | ||||||||
Tax | ||||||||
Stock | ||||||||
Debtors | -152,000 | -820,000 | -400,000 | -1,177,000 | -1,410,000 | 1,949,000 | 4,839,000 | |
Creditors | 537,000 | 97,000 | 116,000 | -1,639,000 | 1,638,000 | 29,000 | 256,000 | |
Accruals and Deferred Income | -1,026,000 | -317,000 | -671,000 | -1,170,000 | 487,000 | 294,000 | 4,174,000 | |
Deferred Taxes & Provisions | ||||||||
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | 557,000 | -634,000 | 858,000 | 1,268,000 | -1,168,000 | -533,000 | 16,933,000 | |
cash flow from investments | -557,000 | 634,000 | -858,000 | -1,268,000 | 1,168,000 | 533,000 | -16,933,000 | |
Financing Activities | ||||||||
Bank loans | ||||||||
Group/Directors Accounts | ||||||||
Other Short Term Loans | 32,000 | 438,000 | ||||||
Long term loans | -470,000 | -436,000 | -408,000 | -380,000 | -351,000 | -170,000 | 2,849,000 | |
Hire Purchase and Lease Commitments | ||||||||
other long term liabilities | -1,500,000 | 1,500,000 | -1,748,000 | 1,419,000 | 329,000 | |||
share issue | ||||||||
interest | ||||||||
cash flow from financing | -438,000 | 2,000 | -1,908,000 | 1,120,000 | -2,099,000 | 2,203,000 | 19,750,000 | |
cash and cash equivalents | ||||||||
cash | -1,164,000 | -1,209,000 | -890,000 | -756,000 | 67,000 | 1,087,000 | 5,152,000 | |
overdraft | -408,000 | 28,000 | 27,000 | 22,000 | 11,000 | 320,000 | ||
change in cash | -1,164,000 | -801,000 | -918,000 | -783,000 | 45,000 | 1,076,000 | 4,832,000 |
Perform a competitor analysis for university hospitals bristol & weston charity by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in BS1 area or any other competitors across 12 key performance metrics.
UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY group structure
University Hospitals Bristol & Weston Charity has 2 subsidiary companies.
Ultimate parent company
UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY
10394287
2 subsidiaries
University Hospitals Bristol & Weston Charity currently has 16 directors. The longest serving directors include Mr James Fox (Jan 2017) and Mr Lee Aston (Jul 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr James Fox | England | 62 years | Jan 2017 | - | Director |
Mr Lee Aston | 54 years | Jul 2018 | - | Director | |
Mr Steve Bluff | England | 56 years | Jul 2018 | - | Director |
Mr Stephen Campling | England | 73 years | May 2019 | - | Director |
Mrs Jane Palmer | England | 67 years | May 2019 | - | Director |
Mrs Deirdre Fowler | England | 58 years | Jul 2021 | - | Director |
Mrs Clare Titley | England | 47 years | May 2022 | - | Director |
Mr Carlos Leira | 53 years | May 2022 | - | Director | |
Mr Terence Rice | 63 years | May 2022 | - | Director | |
Mr Carlos Leira | 53 years | May 2022 | - | Director |
P&L
March 2024turnover
3.3m
+33%
operating profit
163.5k
0%
gross margin
46.8%
+1.29%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
18.7m
+0.01%
total assets
22.6m
-0.03%
cash
2.3m
-0.34%
net assets
Total assets minus all liabilities
company number
10394287
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
86101 - Hospital activities
88990 - Other social work activities without accommodation n.e.c.
incorporation date
September 2016
age
9
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
March 2024
previous names
above & beyond (October 2021)
accountant
-
auditor
MOORE KINGSTON SMITH LLP
address
whitefriars lewins mead, bristol, BS1 2NT
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to university hospitals bristol & weston charity.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|